34948-62-4

Basic information

• Product Name: [(2S,3R,4R,5R,6R)-6-(acetoxymethyl)-(3-amino)tetrahydro-2H-pyran-2,4,5-triyl]triacetate hydrochloride
• Synonyms: [(2S,3R,4R,5R,6R)-6-(acetoxymethyl)-(3-amino)tetrahydro-2H-pyran-2,4,5-triyl]triacetate hydrochloride
• CAS NO: 34948-62-4
• Molecular Weight: 383.783
• Mol File: 34948-62-4.mol
• Article Data: 48

Chemical Properties

• CAS DataBase Reference: [(2S,3R,4R,5R,6R)-6-(acetoxymethyl)-(3-amino)tetrahydro-2H-pyran-2,4,5-triyl]triacetate hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: [(2S,3R,4R,5R,6R)-6-(acetoxymethyl)-(3-amino)tetrahydro-2H-pyran-2,4,5-triyl]triacetate hydrochloride(34948-62-4)
• EPA Substance Registry System: [(2S,3R,4R,5R,6R)-6-(acetoxymethyl)-(3-amino)tetrahydro-2H-pyran-2,4,5-triyl]triacetate hydrochloride(34948-62-4)

Safety Data

• Hazardous Substances Data: 34948-62-4(Hazardous Substances Data)

Usage

General Description

[(2S,3R,4R,5R,6R)-6-(acetoxymethyl)-(3-amino)tetrahydro-2H-pyran-2,4,5-triyl]triacetate hydrochloride is a chemical compound with the formula C14H21NO9?HCl. It is a derivative of the sugar molecule and has three acetate groups attached to the pyran ring. The presence of the hydrochloride salt indicates that it is a water-soluble form of the compound. This chemical may have potential applications in the field of pharmaceuticals, specifically in drug delivery systems or as a building block for the synthesis of other compounds. Its specific properties and potential uses would need to be further studied and determined through research and experimentation.

Upstream product

• 7597-81-1 (2S,3R,4R,5S,6R)-6-(acetoxymethyl)-3-((E)-(4-methoxybenzylidene)amino)tetrahydro-2Hpyran-2,4,5-triyl triacetate 
• 14131-63-6 D-glucosamine hydrochloride 
• 75-36-5 acetyl chloride 
• 90176-39-9 2-benzylideneamino-2-deoxy-β-D-glucopyranose 
• 51471-40-0 6-(hydroxymethyl)-3-[4-methoxybenzylideneamino]tetrahydropyran-2,4,5-triol 
• 114297-26-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-{[(4-methoxyphenyl)methylidene]amino}-D-glucopyranose 
• 7597-81-1 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(4-methoxybenzylidene)amino-β-D-glucopyranose 
• 14257-79-5 β-D-galactosamine hydrochloride 
• 233595-32-9 C₁₄H₁₉NO₆ 
• 1772-03-8 D-(+)-galactosamine hydrochloride 
• 882503-87-9 2-[(E)-cinnamylidene]amino-2-deoxy-D-galactopyranose 
• 34948-61-3 N-(4-Methoxy-benzyliden)-tetra-O-acetyl-2-amino-2-desoxy-β-D-galactopyranose 
• 1078691-95-8 (+)-D-glucosamine hydrochloride 
• 108-24-7 acetic anhydride 

Downstream Products

• 141280-19-5 2--L-phenylalanylamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucose 
• 141280-20-8 2--L-prolylamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucose 
• 141280-21-9 2--L-valyl>-L-prolylamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucose 
• 163152-13-4 1,3,4,6-tetra-O-acetyl-2-<2-(chloroacetoxymethyl)benzoylamido>-2-deoxy-β-D-glucopyranose 
• 35946-66-8 2-(acetoxymethyl)-5-{[(benzyloxy)carbonyl]amino}tetrahydropyran-3,4,6-triyl triacetate 
• 122210-05-3 1,3,4,6-tetra-O-acetyl-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-β-D-glucopyranose 
• 175229-70-6 1-acetoxy-3,4,6-tri-O-acetyl-2-deoxy-2-(4,5-dichlorophthalimido)-β-D-glucopyranoside 
• 7512-17-6 2-acetamido-2-deoxy-D-glucose 
• 10583-48-9 2-N,N-Diacetyl-2-amino-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose 
• 10293-54-6 3,4,6-tri-O-acetyl-2-(N-acetylacetamido)-1,5-anhydro-2-deoxy-D-arabino-hex-1-enitol 
• 3006-60-8 2-acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-β-D-glucopyranose 
• 3006-60-8 Acetic acid (2R,3R,4R,5S,6R)-2,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-4-yl ester 
• 4780-17-0 1,3,4,6-tetra-O-acetyl-2-deoxy-2-isocyanato-β-D-glucopyranose 
• 945219-31-8 p-methoxyphenyl 3,4,6-tri-O-acetyl-2-N-dimethylphosphoryl-2-deoxy-β-D-glucopyranoside 

Relevant articles and documents

Profiling of: Haemophilus influenzae strain R2866 with carbohydrate-based covalent probes

We demonstrate the application of four covalent probes based on anomerically pure d-galactosamine and d-glucosamine scaffolds for the profiling of Haemophilus influenzae strain R2866. The probes have been used successfully for the labelling of target prot

GOLD COMPOSITIONS AND METHODS OF USE THEREOF

Gold compounds and pharmaceutically acceptable salts thereof are disclosed. Certain compounds and salts are active as antibacterial, antifungal, and/or anti-parasitic agents. The disclosure provides pharmaceutical compositions containing the gold compounds. Methods of using the gold compounds to treat bacterial infections are disclosed.

GLYCOSYLATED 3-SUBSTITUTED FLUOROQUINOLONE DERIVATIVES, PREPARATION METHODS THEREOF, AND THEIR USE IN THE TREATMENT OF ANTIMICROBIAL INFECTIONS

The present disclosure relates to 3-substituted fluoroquinolone derivatives, and more particularly to glycosylated 3-substitutred fluoroquinolone derivatives, methods of preparation thereof, and uses thereof for treating microbial infections.